Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phytochemical synergies in BK002: advanced molecular docking insights for targeted prostate cancer therapy

17 Feb 2025

Abstract excerpt

Achyranthes japonica (Miq.) Nakai (AJN) and Melandrium firmum (Siebold and Zucc.) Rohrb. (MFR) are medicinal plants recognized for their bioactive phytochemicals, including ecdysteroids, anthraquinones, and flavonoids. This study investigates the anticancer properties of key constituents of these plants, focusing on the BK002 formulation, a novel combination of AJN and MFR. Specifically, the research employs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Estrogen and related hormone effects
Share to Prostate Cancer Treatment and Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40034825
DOI: 10.3389/fphar.2025.1504618

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 19 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Phytochemical synergies in BK002: advanced molecular docking insights for targeted prostate cancer therapyPMID 40034825Read ↗

Bioinformatics and system biology approaches for identifying potential therapeutic targets for prostate cancerSemantic proximity Read ↗

Deciphering the role of zingiber officinale phytochemicals for the treatment of prostate cancer: Interactions of phytochemicals with androgen receptor prostate cancer mutant H874Y ligand binding domain.Semantic proximity Read ↗

Integrative genomic and bioinformatic prioritization of drug repurposing candidates for prostate cancer.Semantic proximity Read ↗

A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancerSemantic proximity Read ↗

Molecules targeting the androgen receptor (AR) signaling axis beyond the AR‐Ligand binding domainSemantic proximity Read ↗

Decoding the mechanism of andrographolide to combat hepatocellular carcinoma: a network pharmacology integrated molecular docking and dynamics approachSemantic proximity Read ↗

Exploring the Reproductive Mechanisms of Fertility-Boosting No.1 and Fertility-Preserving Tang by Network pharmacology and molecular dockingSemantic proximity Read ↗

Network Pharmacology and Molecular Dynamics Identified Potential Androgen Receptor-Targeted Metabolites in Crocus alatavicusSemantic proximity Read ↗

Procyanidin B2 3,3″-di-O-gallate, a Biologically Active Constituent of Grape Seed Extract, Induces Apoptosis in Human Prostate Cancer Cells Via Targeting NF-κB, Stat3, and AP1 Transcription FactorsSemantic proximity Read ↗

Flavonoids as Epigenetic Modulators for Prostate Cancer PreventionSemantic proximity Read ↗

In silico exploration of anti-prostate cancer compounds from differential expressed genesSemantic proximity Read ↗

Integrating machine learning driven virtual screening and molecular dynamics simulations to identify potential inhibitors targeting PARP1 against prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.